These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 17313936)

  • 1. [Malignant struma ovarii: false positive PET image for suspected metastasis due to sarcoidosis].
    Kunstmann L; Bständig B; Brucker-Davis F; Mouroux J; Rigot P; Fenichel P
    Ann Endocrinol (Paris); 2007 Feb; 68(1):51-4. PubMed ID: 17313936
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Late Manifestation of Struma Peritonei and Widespread Functioning Lesions in the Setting of Struma Ovarii Simulating Highly Differentiated Follicular Carcinoma.
    Ranade R; Rachh S; Basu S
    J Nucl Med Technol; 2015 Sep; 43(3):231-3. PubMed ID: 25537757
    [TBL] [Abstract][Full Text] [Related]  

  • 3. False-positive finding in FDG-PET in a patient with seminoma and sarcoidosis.
    Liepe K
    Acta Clin Belg; 2015 Apr; 70(2):138-40. PubMed ID: 25409626
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pulmonary metastasis of struma ovarii: a case report.
    Ruel IF; Fierrard H; Vercellino L; Bernard L; Hindie E; Duron F; Toubert ME
    Clin Nucl Med; 2010 Sep; 35(9):692-4. PubMed ID: 20706043
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Value of FDG PET in papillary thyroid carcinoma with negative 131I whole-body scan.
    Chung JK; So Y; Lee JS; Choi CW; Lim SM; Lee DS; Hong SW; Youn YK; Lee MC; Cho BY
    J Nucl Med; 1999 Jun; 40(6):986-92. PubMed ID: 10452315
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FDG PET for esophageal cancer complicated by sarcoidosis mimicking mediastinal and hilar lymph node metastases: two case reports.
    Takanami K; Kaneta T; Yamada T; Kinomura S; Yamada S; Fukuda H; Takahashi S
    Clin Nucl Med; 2008 Apr; 33(4):258-61. PubMed ID: 18356663
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidental diagnosis of struma ovarii after thyroidectomy for thyroid cancer: functional imaging studies and follow-up.
    Ghander C; Lussato D; Conte Devolx B; Mundler O; Taïeb D
    Gynecol Oncol; 2006 Aug; 102(2):378-80. PubMed ID: 16516952
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Malignant struma ovarii--a case report and review of the literature.
    Hatami M; Breining D; Owers RL; Del Priore G; Goldberg GL
    Gynecol Obstet Invest; 2008; 65(2):104-7. PubMed ID: 17890867
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 18F-FDG PET/CT in patients with suspected recurrent or metastatic well-differentiated thyroid cancer.
    Shammas A; Degirmenci B; Mountz JM; McCook BM; Branstetter B; Bencherif B; Joyce JM; Carty SE; Kuffner HA; Avril N
    J Nucl Med; 2007 Feb; 48(2):221-6. PubMed ID: 17268018
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Respective roles of thyroglobulin, radioiodine imaging, and positron emission tomography in the assessment of thyroid cancer.
    Lind P; Kohlfürst S
    Semin Nucl Med; 2006 Jul; 36(3):194-205. PubMed ID: 16762610
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Struma ovarii maligna.
    Matysiak-Grzes M; Fischbach J; Gut P; Klimowicz A; Gryczynska M; Wasko R; Ruchala M
    Neuro Endocrinol Lett; 2013; 34(2):97-101. PubMed ID: 23645304
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of benign and malignant thyroid tissue in ovarian teratomas and the importance of multimodal management as illustrated by a BRAF-positive follicular variant of papillary thyroid cancer.
    Wolff EF; Hughes M; Merino MJ; Reynolds JC; Davis JL; Cochran CS; Celi FS
    Thyroid; 2010 Sep; 20(9):981-7. PubMed ID: 20718682
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complete Remission After Single Radioiodine Therapy in Malignant Struma Ovarii With Bone and Lymph Node Metastases.
    Seifert P; Gühne F; Theurer S; Freesmeyer M
    Clin Nucl Med; 2019 Jan; 44(1):42-44. PubMed ID: 30394923
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined [18F]Fluorodeoxyglucose positron emission tomography and computed tomography (FDG-PET/CT) for detection of recurrent, 131I-negative thyroid cancer.
    Finkelstein SE; Grigsby PW; Siegel BA; Dehdashti F; Moley JF; Hall BL
    Ann Surg Oncol; 2008 Jan; 15(1):286-92. PubMed ID: 17882493
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Highly differentiated follicular carcinoma arising from struma ovarii: a report of 3 cases, a review of the literature, and a reassessment of so-called peritoneal strumosis.
    Roth LM; Karseladze AI
    Int J Gynecol Pathol; 2008 Apr; 27(2):213-22. PubMed ID: 18317221
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coexistence of malignant struma ovarii and cervical papillary thyroid carcinoma.
    Leong A; Roche PJ; Paliouras M; Rochon L; Trifiro M; Tamilia M
    J Clin Endocrinol Metab; 2013 Dec; 98(12):4599-605. PubMed ID: 24217901
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Struma ovarii and the thyroid surgeon.
    Gunasekaran S; Kopecka E; Maung KH; England RJ
    J Laryngol Otol; 2012 Aug; 126(8):858-60. PubMed ID: 22624934
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic usefulness of fluorine-18-alpha-methyltyrosine positron emission tomography in combination with 18F-fluorodeoxyglucose in sarcoidosis patients.
    Kaira K; Oriuchi N; Otani Y; Yanagitani N; Sunaga N; Hisada T; Ishizuka T; Endo K; Mori M
    Chest; 2007 Apr; 131(4):1019-27. PubMed ID: 17426205
    [TBL] [Abstract][Full Text] [Related]  

  • 19. F-18-fluorodeoxyglucose positron emission tomography-guided sampling of mediastinal lymph nodes in the diagnosis of cardiac sarcoidosis.
    Simonen P; Lehtonen J; Kandolin R; Schildt J; Marjasuo S; Miettinen H; Airaksinen J; Vihinen T; Tuohinen S; Haataja P; Kupari M
    Am J Cardiol; 2015 Nov; 116(10):1581-5. PubMed ID: 26411357
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Positron emission tomography-computed tomography with (18)F-fluorodeoxyglucose in patients with recurrent differentiated thyroid carcinoma and negative radioiodine scan. Diagnostic performance and relation with tyroglobulin levels].
    Mariscal Labrador E; García Burillo A; Castell-Conesa J; Obiols Alfonso G; Kisiel González N; Barios Profitós M; Aguadé-Bruix S; Mesa Manteca J
    Rev Esp Med Nucl Imagen Mol; 2013; 32(3):146-51. PubMed ID: 22726673
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.